Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company
will be webcasting its presentation at the following two investor
conferences during the month of June 2009.
-
The 8th Annual Needham Life Sciences Conference
New
York, NY.
June 11, 2009
Presentation Time: 11:30 AM Eastern
-
The Jefferies 3rd Annual Healthcare Conference
New York, NY.
June
17, 2009
Presentation Time: 1:00 PM Eastern
During these presentations, a member of the company’s senior management
team will provide a corporate overview, including a discussion of
product development programs, recent corporate activities and financial
performance.
A webcast of these presentations will be available both live and by
replay, accessible from the company’s website www.emergentbiosolutions.com
under “Investors”.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the
development, manufacture and commercialization of vaccines and
therapeutics that assist the body’s immune system to prevent or treat
disease. Emergent’s marketed product, BioThrax® (Anthrax
Vaccine Adsorbed), is the only vaccine licensed by the U.S. Food and
Drug Administration for the prevention of anthrax. Emergent’s
development pipeline includes programs focused on anthrax, botulism,
tuberculosis, typhoid, hepatitis B and chlamydia. Additional information
may be found at www.emergentbiosolutions.com.
Emergent BioSolutions Inc.
Investors Contact:
Robert G.
Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media
Contact:
Tracey Schmitt
Director, Corporate Communications
301-795-1800
SchmittT@ebsi.com
